The role of the UPC

News has emerged from the July 10 meeting of the Unified Patent Court (UPC) Preparatory Committee that it is considering a ‘provisional operation’ period for the new court, starting in January 2016.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

7 September 2026 A single phrase in a patent has proved decisive in Biofer’s infringement fight with Vifor, with the Federal Circuit exposing the risks of small claim-drafting choices for life sciences companies.

Pharma

Teva faces scrutiny over efforts to curb generic competition

27 August 2026 Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.

Pharma

Teva and Aurinia settle generics dispute over lupus drug, voclosporin

21 August 2026 Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of Aurinia's Lupkynis.

More features

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

10x Genomics wins latest round in Parse patent dispute

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win

Tempus AI bid to derail DNA patent case hits snag

Teva faces scrutiny over efforts to curb generic competition

FDA targets faster generic approvals in drive to slash drug prices

China-origin biotech assets and the hidden question of IP ownership

The buyers' wishlist: What makes a life sciences deal stack up?

The role of the UPC

More on this story

Editor's picks

Editor's picks

More features